Загрузка...
Immunogenicity and safety of Advax(™), a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen; a randomized controlled Phase 1 study
There is a need for additional safe and effective human vaccine adjuvants. Advax is a novel adjuvant produced from semi-crystalline particles of delta inulin. In animal studies Advax enhanced humoral and cellular immunity to hepatitis B surface antigen (HBsAg) without inducing local or systemic reac...
Сохранить в:
| Опубликовано в: : | Vaccine |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4253909/ https://ncbi.nlm.nih.gov/pubmed/25267153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.09.034 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|